Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA



Deep Insight

Angiogenic factors and cancer therapy
DNA methylation in cancer
FOXP3 expression in tumor cells and its role in cancer progression


AAMP (angio-associated, migratory cell protein)
ACVRL1 (activin A receptor type II-like 1)
ADAMTS9 (ADAM metallopeptidase with thrombospondin type 1 motif, 9)
AKAP12 A kinase (PRKA) anchor protein 12
ANG (angiogenin, ribonuclease, RNase A family, 5)
APLNR (apelin receptor)
AQP1 (aquaporin 1 (Colton blood group))
ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67))
ATP5B (ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide)
AXL (AXL receptor tyrosine kinase)
BAG3 (Bcl-2 associated athanogene 3)
BAK1 (BCL2-antagonist/killer 1)
BEX2 (brain expressed X-linked 2)
CCR1 (chemokine (C-C motif) receptor 1)
CD151 (CD151 molecule (Raph blood group))
CD248 (CD248 molecule, endosialin)
CD47 (Cluster of Differentiation 47)
CD59 (CD59 molecule, complement regulatory protein)
ADGRE5 (CD97 molecule)
CLIC4 (chloride intracellular channel 4)
CPM (carboxypeptidase M)
CX3CL1 (chemokine (C-X3-C motif) ligand 1)
CXCL10 (chemokine (C-X-C motif) ligand 10)
CXCL12 (chemokine (C-X-C motif) ligand 12)
CXCL17 (chemokine (C-X-C motif) ligand 17)
CXCL5 (chemokine (C-X-C motif) ligand 5)
CXCR1 (chemokine (C-X-C motif) receptor 1)
CYP4B1 (cytochrome P450, family 4, subfamily B, polypeptide 1)
CYR61 (cysteine-rich, angiogenic inducer, 61)
DIRAS3 (DIRAS family, GTP-binding RAS-like 3)
DLX4 (distal-less homeobox 4)
DPP4 (dipeptidyl-peptidase 4)
ECM1 (extracellular matrix protein 1)
EDIL3 (EGF-Like Repeats And Discoidin I-Like Domains 3)
EEF2K (eukaryotic elongation factor 2 kinase)
ENG (endoglin)
ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2)
ENPP7 (ectonucleotide pyrophosphatase/phosphodiesterase 7)
EPHA2 (EPH receptor A2)
EPS8 (epidermal growth factor receptor pathway substrate 8)
ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian))
FAP (fibroblast activation protein alpha)
FBLN5 (fibulin 5)
FGF2 (fibroblast growth factor 2 (basic))
FGF8 (fibroblast growth factor 8 (androgen-induced))
VEGFD (c-fos induced growth factor (vascular endothelial growth factor D))
FPR1 (formyl peptide receptor 1)
GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa)
HIPK2 (homeodomain interacting protein kinase 2)
HLTF (helicase-like transcription factor)
ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein)
IGFBP6 (insulin-like growth factor binding protein 6)
IL17A (interleukin 17A)
ILK (integrin-linked kinase)
ING4 (inhibitor of growth family, member 4)
KDR (kinase insert domain receptor)/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
KLF5 : Kruppel-like factor 5 (intestinal)
LGALS3 (lectin, galactoside-binding, soluble, 3)
LPAR2 (lysophosphatidic acid receptor 2)
MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor))
MIR100 (microRNA 100)
MIR107 (MicroRNA 107)
MMP14 (matrix metallopeptidase 14 (membrane-inserted))
MMP19 (matrix metallopeptidase 19)
MMP2 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase).
MMP9 (matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase))
MRC1 (mannose receptor, C type 1)
MST1 (macrophage stimulating 1 (hepatocyte growth factor-like))
NAMPT (nicotinamide phosphoribosyltransferase)
NCOA1 (Nuclear receptor coactivator 1)
NDRG1 (N-myc downstream regulated 1)
NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13)
NKX2-3 (NK2 homeobox 3)
NOTCH1 (Notch homolog 1, translocation-associated (Drosophila))
NOTCH2 (Notch homolog 2 (Drosophila))
NOTCH3 (Notch homolog 3 (Drosophila))
NPY1R (neuropeptide Y receptor Y1)
NR3C1 (nuclear receptor subfamily 3, group C, member 1/glucocorticoid receptor)
NT5E (5'-nucleotidase, ecto (CD73))
PF4 (platelet factor 4)
PF4V1 (Platelet Factor 4 Variant 1)
PGR (progesterone receptor)
PIM1 (pim-1 oncogene)
PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent))
PLCG1 (Phospholipase C, Gamma 1)
PML (promyelocytic leukemia)
PTK7 (PTK7 protein tyrosine kinase 7)
PTN (pleiotrophin)
PTPN14 (protein tyrosine phosphatase, non-receptor type 14)
REST (RE1-silencing transcription factor)
RET (REarranged during Transfection)
RLN2 (relaxin 2)
S100A4 (S100 Calcium Binding Protein A4)
SGK1 (serum/glucocorticoid regulated kinase 1)
TEK (TEK tyrosine kinase, endothelial)
TGFBR3 (transforming growth factor, beta receptor III)
THBS1 (thrombospondin-1)
THRB (Thyroid Hormone Receptor, Beta)
TIE1 (tyrosine kinase with immunoglobulin-like and EGF-like domains 1)
TIMP2 (TIMP metallopeptidase inhibitor 2)
TMSB10 (thymosin beta 10)
TNC (tenascin C (hexabrachion))
TNFSF15 (tumor necrosis factor (ligand) superfamily, member 15)
TSPAN8 (tetraspanin 8)
TYMP (thymidine phosphorylase)
UTS2 (urotensin 2)
VAV3 (vav 3 guanine nucleotide exchange factor)
VHL (von Hippel-Lindau tumor suppressor)
WFDC1 (WAP four-disulfide core domain 1)


Figure from ACVRL1

Figure from ADAMTS9

Figure from APLNR

Figure from ATP5B

Figure from AXL

Figure from BAK1

Figure from CCR1

Figure from CD151

Figure from CD248

Figure from CD97

Figure from CLIC4

Figure from CXCL12

Figure from CXCR1

Figure from DIRAS3

Figure from DPP4

Figure from ECM1

Figure from ENPP2

Figure from ENPP7

Figure from EPHA2

Figure from EPHA2

Figure from ERBB3

Figure from FBLN5

Figure from FGF2

Figure from FPR1

Figure from GBP1

Figure from IGFBP6

Figure from ILK

Figure from ILK

Figure from KDR

Figure from KLF5

Figure from LPAR2

Figure from MIR100

Figure from MIR100

Figure from MMP14

Figure from MMP2

Figure from MRC1

Figure from MST1

Figure from NDRG1

Figure from NDUFA13

Figure from NKX2-3

Figure from NR3C1

Figure from PF4

Figure from PLCG1

Figure from PTK7

Figure from PTPN14

Figure from SGK1

Figure from TEK

Figure from TEK

Figure from TGFBR3

Figure from TIE1

Figure from UTS2

Figure from VHL


WrittenOct 2009Jean-Loup Huret
UpdatedJan 2021Jean-Loup Huret and Philippe Dessen


This paper should be referenced as such :
, Huret JL, Dessen P.. Angiogenesis. Atlas Genet Cytogenet Oncol Haematol. Jan 2021 .

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jan 13 17:37:03 CET 2021

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA